SEC Form 4 · accession 0001325812-15-000017
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Hodgman
Director
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 6:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2015 | A | 1,000 | $0.00 | A | 6,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $13.90 | Feb 27, 2015 | A | 15,000 | A | — | Feb 27, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1This Restricted Stock Award will vest in full on the first anniversary of the Issuer's next annual meeting of stockholders.
- F2This option will vest at a rate of 25% annually over four years to commence on the first anniversary of the Issuer's next annual meeting of stockholders.